AXIM (AXIM Biotechnologies) Total Assets: $3.22 Mil (As of Jun. 2025)


What is AXIM Biotechnologies Total Assets?

AXIM Biotechnologies AXIM Total Assets is $3.22 Mil as of Jun. 2025. The stock has 7 warning signs investors should review.

AXIM Biotechnologies's Total Assets for the quarter that ended in Jun. 2025 was $3.22 Mil.

During the past 12 months, AXIM Biotechnologies's average Total Assets Growth Rate was -16.10% per year. During the past 3 years, the average Total Assets Growth Rate was -10.90% per year. During the past 5 years, the average Total Assets Growth Rate was 9.50% per year. During the past 10 years, the average Total Assets Growth Rate was 44.90% per year.

During the past 13 years, AXIM Biotechnologies's highest 3-Year average Total Assets Growth Rate was 332.70%. The lowest was -51.00%. And the median was 20.30%.

Total Assets is connected with ROA %. AXIM Biotechnologies's annualized ROA % for the quarter that ended in Jun. 2025 was 45.05%. Total Assets is also linked to Revenue through Asset Turnover. AXIM Biotechnologies's Asset Turnover for the quarter that ended in Jun. 2025 was 0.00.

AXIM Biotechnologies  (OTCPK:AXIM) Total Assets Explanation

Total Assets is connected with ROA %.

AXIM Biotechnologies's annualized ROA % for the quarter that ended in Jun. 2025 is

ROA %=Net Income (Q: Jun. 2025 )/( (Total Assets (Q: Mar. 2025 )+Total Assets (Q: Jun. 2025 ))/ count )
=1.48/( (3.346+3.224)/ 2 )
=1.48/3.285
=45.05 %

Note: The Net Income data used here is four times the quarterly (Jun. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

AXIM Biotechnologies's Asset Turnover for the quarter that ended in Jun. 2025 is

Asset Turnover
=Revenue (Q: Jun. 2025 )/( (Total Assets (Q: Mar. 2025 )+Total Assets (Q: Jun. 2025 ))/ count )
=0/( (3.346+3.224)/ 2 )
=0/3.285
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

AXIM Biotechnologies Total Assets Related Terms

AXIM Biotechnologies Total Assets Historical Data

* Premium members only.

The historical data trend for AXIM Biotechnologies's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AXIM Biotechnologies Total Assets Chart

AXIM Biotechnologies Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.31 5.32 4.21 4.12 3.45

AXIM Biotechnologies Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.94 3.73 3.45 3.35 3.22

AXIM Biotechnologies Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

AXIM Biotechnologies's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets=Total Equity (A: Dec. 2024 )+Total Liabilities (A: Dec. 2024 )
=-10.42+13.867
=3.45

AXIM Biotechnologies's Total Assets for the quarter that ended in Jun. 2025 is calculated as

Total Assets=Total Equity (Q: Jun. 2025 )+Total Liabilities (Q: Jun. 2025 )
=-10.426+13.65
=3.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $3.22 Mil mean?
AXIM Biotechnologies (AXIM) has a Total Assets of $3.22 Mil as of Jun. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on AXIM Biotechnologies and its competitors.
Is AXIM Biotechnologies' Total Assets too high?
AXIM Biotechnologies' current Total Assets is $3.22 Mil.
How does AXIM Biotechnologies' Total Assets compare to HEPA and SCNI?
AXIM Biotechnologies' Total Assets of $3.22 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on AXIM Biotechnologies and its competitors. AXIM Biotechnologies's current Total Assets is $3.22 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AXIM Biotechnologies stock overvalued right now?
AXIM Biotechnologies (AXIM) has a current Total Assets of $3.22 Mil. The current Total Assets is $3.22 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For AXIM Biotechnologies (AXIM), the current Total Assets is $3.22 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AXIM Biotechnologies Business Description

Address 6048 Cornerstone Court West, Suite E1, San Diego, CA, USA, 92121
AXIM Biotechnologies Inc is a integrated research and development company and developer of diagnostic healthcare solutions serving to enhance the health of people. The company focuses on improving the landscape for the diagnosis of ophthalmological conditions such as Dry Eye Disease through rapid diagnostic tests. Additionally, The company owns IP and has conducted research on SARS-CoV-2 (COVID-19) rapid neutralizing antibody tests to detect levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells.